Education
About Us
Working with TipRanks
Follow Us
Procter & Gamble Health Ltd. (IN:PGHL)
:PGHL
Total Valuation
Procter & Gamble Health Ltd. has a market cap or net worth of ₹98.28B. The enterprise value is ₹95.51B.
Market Cap₹98.28B
Enterprise Value₹95.51B
Share Statistics
Procter & Gamble Health Ltd. has 16,599,382 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,599,382
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Procter & Gamble Health Ltd.’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 77.20%.
Return on Equity (ROE)0.37
Return on Assets (ROA)0.25
Return on Invested Capital (ROIC)77.20%
Return on Capital Employed (ROCE)1.05
Revenue Per Employee8.62M
Profits Per Employee1.50M
Employee Count1,336
Asset Turnover1.45
Inventory Turnover3.03
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio41.9
PS Ratio0.00
PB Ratio18.11
Price to Fair Value15.76
Price to FCF211.47
Price to Operating Cash Flow197.58
PEG Ratio6.26
Income Statement
In the last 12 months, Procter & Gamble Health Ltd. had revenue of 11.51B and earned 2.01B in profits. Earnings per share was 121.07.
Revenue11.51B
Gross Profit8.21B
Operating Income6.07B
Pretax Income2.73B
Net Income2.01B
EBITDA3.07B
Earnings Per Share (EPS)121.07
Cash Flow
In the last 12 months, operating cash flow was 492.20M and capital expenditures -32.30M, giving a free cash flow of 459.90M billion.
Operating Cash Flow492.20M
Free Cash Flow459.90M
Free Cash Flow per Share27.71
Dividends & Yields
Procter & Gamble Health Ltd. pays an annual dividend of ₹140, resulting in a dividend yield of 2.37%
Dividend Per Share₹140
Dividend Yield2.37%
Payout Ratio87.38%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.50
52-Week Price Change14.04%
50-Day Moving Average5.74K
200-Day Moving Average5.34K
Relative Strength Index (RSI)51.98
Average Volume (3m)570.00
Important Dates
Procter & Gamble Health Ltd. upcoming earnings date is Aug 20, 2025, TBA (Confirmed).
Last Earnings DateMay 29, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend DateAug 22, 2025
Financial Position
Procter & Gamble Health Ltd. as a current ratio of 2.39, with Debt / Equity ratio of 1.42%
Current Ratio2.39
Quick Ratio1.90
Debt to Market Cap0.00
Net Debt to EBITDA-0.76
Interest Coverage Ratio843.03
Taxes
In the past 12 months, Procter & Gamble Health Ltd. has paid 723.40M in taxes.
Income Tax723.40M
Effective Tax Rate0.26
Enterprise Valuation
Procter & Gamble Health Ltd. EV to EBITDA ratio is 26.82, with an EV/FCF ratio of 39.92.
EV to Sales7.16
EV to EBITDA26.82
EV to Free Cash Flow39.92
EV to Operating Cash Flow36.12
Balance Sheet
Procter & Gamble Health Ltd. has ₹2.06B in cash and marketable securities with ₹76.20M in debt, giving a net cash position of -₹1.98B billion.
Cash & Marketable Securities₹2.06B
Total Debt₹76.20M
Net Cash-₹1.98B
Net Cash Per Share-₹119.55
Tangible Book Value Per Share₹323.66
Margins
Gross margin is 63.10%, with operating margin of 52.72%, and net profit margin of 17.46%.
Gross Margin63.10%
Operating Margin52.72%
Pretax Margin23.74%
Net Profit Margin17.46%
EBITDA Margin26.70%
EBIT Margin24.32%
Analyst Forecast
The average price target for Procter & Gamble Health Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1.30%
EPS Growth Forecast36.21%